Principal Financial Group Inc Chroma Dex Corp. Transaction History

Principal Financial Group Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 09, 2022	SELL	$3.74 - $6.7 $87,396 - $156,565	-23,368 Closed	0 $0
Q3 2021 Nov 09, 2021	BUY	$6.05 - $10.41 $48,164 - $82,874	7,961 Added 51.67%	23,368 $146,000
Q2 2021 Aug 10, 2021	BUY	$6.66 - $10.92 $102,610 - $168,244	15,407 New	15,407 $151,000
Q1 2021 May 10, 2021	SELL	$4.59 - $18.74 $48,291 - $197,163	-10,521 Closed	0 $0
Q4 2020 Feb 08, 2021	BUY	$3.93 - $5.5 $41,347 - $57,865	10,521 New	10,521 $51,000

17.2M

66.7K

8.2K

Ticker CDXC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,350,896
Market Cap $362M
Description
ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingre...

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

Stay updated on Principal Financial Group Inc with notifications on news.